SE8902148L - Syntetiska peptid antigen foer detektion av htlv-1 infektion - Google Patents

Syntetiska peptid antigen foer detektion av htlv-1 infektion

Info

Publication number
SE8902148L
SE8902148L SE8902148A SE8902148A SE8902148L SE 8902148 L SE8902148 L SE 8902148L SE 8902148 A SE8902148 A SE 8902148A SE 8902148 A SE8902148 A SE 8902148A SE 8902148 L SE8902148 L SE 8902148L
Authority
SE
Sweden
Prior art keywords
htlv
infection
detection
antigen
peptides
Prior art date
Application number
SE8902148A
Other languages
English (en)
Other versions
SE467542B (sv
SE8902148D0 (sv
Inventor
A Vahlne
Original Assignee
Virovahl Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virovahl Sa filed Critical Virovahl Sa
Priority to SE8902148A priority Critical patent/SE467542B/sv
Publication of SE8902148D0 publication Critical patent/SE8902148D0/sv
Priority to CA002062713A priority patent/CA2062713A1/en
Priority to EP97103408A priority patent/EP0814090A1/en
Priority to FI915702A priority patent/FI915702A0/fi
Priority to JP2509469A priority patent/JP2650217B2/ja
Priority to KR1019910701844A priority patent/KR0151860B1/ko
Priority to AU59453/90A priority patent/AU638727B2/en
Priority to HU906639A priority patent/HUT61323A/hu
Priority to EP90917762A priority patent/EP0477301A1/en
Priority to PCT/SE1990/000407 priority patent/WO1990015820A1/en
Priority to ZA904565A priority patent/ZA904565B/xx
Priority to NZ234049A priority patent/NZ234049A/xx
Publication of SE8902148L publication Critical patent/SE8902148L/sv
Priority to NO91914755A priority patent/NO914755L/no
Publication of SE467542B publication Critical patent/SE467542B/sv
Priority to AU48906/93A priority patent/AU654240B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8902148A 1989-06-13 1989-06-13 Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar SE467542B (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE8902148A SE467542B (sv) 1989-06-13 1989-06-13 Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar
PCT/SE1990/000407 WO1990015820A1 (en) 1989-06-13 1990-06-12 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
AU59453/90A AU638727B2 (en) 1989-06-13 1990-06-12 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
EP90917762A EP0477301A1 (en) 1989-06-13 1990-06-12 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
FI915702A FI915702A0 (fi) 1989-06-13 1990-06-12 Peptider och daerav erhaollna antikroppar foer diagnos av vaccination emot htlv-1 infektion.
JP2509469A JP2650217B2 (ja) 1989-06-13 1990-06-12 Ｈｔｌｖ―１感染の診断、治療及び予防接種のためのペプチド
KR1019910701844A KR0151860B1 (ko) 1989-06-13 1990-06-12 Htlv-1 감염의 진단, 치료 및 왁찐 접종용 펩타이드 및 그것으로부터 유도된 항체
CA002062713A CA2062713A1 (en) 1989-06-13 1990-06-12 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
HU906639A HUT61323A (en) 1989-06-13 1990-06-12 And treating htlv-1 peptides and antibodies against them for diagnosting htlv-1 infection and for vaccination against it
EP97103408A EP0814090A1 (en) 1989-06-13 1990-06-12 Peptides and antibodies derived therefrom for the diagnosis of, therapy for and vaccination against htlv-1 infection
NZ234049A NZ234049A (en) 1989-06-13 1990-06-13 Peptide epitopes of, and antibodies to htlv-1
ZA904565A ZA904565B (en) 1989-06-13 1990-06-13 Peptides and antibodies derived therefrom for the diagnosis of therapy for and vaccination against htlv-1 infection
NO91914755A NO914755L (no) 1989-06-13 1991-12-04 Peptider og derav deriverte motstoffer for diagnose av, terapi for og vaksinasjon mot htlv-1 infeksjon
AU48906/93A AU654240B2 (en) 1989-06-13 1993-10-08 A method of eliciting the production of antibodies against HTLV-1 in mammals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902148A SE467542B (sv) 1989-06-13 1989-06-13 Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar

Publications (3)

Publication Number Publication Date
SE8902148D0 SE8902148D0 (sv) 1989-06-13
SE8902148L true SE8902148L (sv) 1990-12-14
SE467542B SE467542B (sv) 1992-08-03

Family

ID=20376281

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902148A SE467542B (sv) 1989-06-13 1989-06-13 Syntetiska peptidantigener, immuniserande komposition och immunanalys foer htlv-1 antikroppar

Country Status (11)

Country Link
EP (2) EP0477301A1 (sv)
JP (1) JP2650217B2 (sv)
KR (1) KR0151860B1 (sv)
AU (2) AU638727B2 (sv)
CA (1) CA2062713A1 (sv)
FI (1) FI915702A0 (sv)
HU (1) HUT61323A (sv)
NZ (1) NZ234049A (sv)
SE (1) SE467542B (sv)
WO (1) WO1990015820A1 (sv)
ZA (1) ZA904565B (sv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643714A (en) * 1986-12-31 1997-07-01 Genelabs Technologies, Inc. Method and assay for HTLV
JP2807287B2 (ja) * 1989-10-13 1998-10-08 株式会社医学生物学研究所 ペプチドおよびその用途
FI910245A7 (sv) * 1990-01-24 1991-07-25 United Biomedical Inc Syntetiska peptidkompositioner med immunoreaktivitet mot HTLV-antikroppar
WO1992004046A1 (en) * 1990-08-29 1992-03-19 The United States Of America, Represented By The Secretary, United States Department Of Commerce Novel peptide antigens and immunoassays, test kits and vaccines using the same
US5866137A (en) * 1990-10-12 1999-02-02 Benjamin Rovinski Self-assembled, non-infectious, non-replicating; immunogenic retrovirus-like particles comprising modified HIV genomes devoid of long terminal repeats and chimeric envelope glycoproteins
EP0677117B1 (en) * 1991-07-10 1999-05-26 Abbott Laboratories Differentiation of htlv-i and htlv-ii using synthetic peptides
US5773211A (en) * 1991-07-10 1998-06-30 Abbott Laboratories Differentiation of HTLV-I and HTLV-II using synthetic peptides
PT643835E (pt) * 1992-02-24 2001-10-30 Genelabs Tech Inc Ensaio e metodo para htlv-i/htlv-ii
US6406841B1 (en) 1993-07-01 2002-06-18 Abbott Laboratories Methods for the detection of HTLV-II antibodies employing novel HTLV-II NRA envelope peptides
CA2179381A1 (en) * 1993-12-20 1995-06-29 Jessie W. Shih Differentiation of htlv-i and htlv-ii using synthetic peptides
FR2844514B1 (fr) * 2002-09-16 2007-10-19 Neovacs Produit immunogene stable comprenant des heterocomplexes antigeniques, compositions les contenant et procede de preparation
JP2015215244A (ja) * 2014-05-12 2015-12-03 富士レビオ株式会社 免疫測定における抗ｈｔｌｖ抗体の検出感度を向上させる方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1249395A (en) * 1982-09-30 1989-01-24 Tetsuya Tachikawa Human leukemia virus-related peptides, a process for production thereof, antibodies of the peptides and a process for production of the antibodies
CA1262014A (en) * 1983-01-07 1989-09-26 Mitsuaki Yoshida Human leukemia virus-related peptides, antibodies of the peptides and a process for production of the antibodies
JPS6028993A (ja) * 1983-07-22 1985-02-14 Otsuka Pharmaceut Co Ltd ヒト白血病ウイルス関連ペプチド
US4689398A (en) * 1984-06-20 1987-08-25 Ortho Diagnostic Systems Inc. HTLV test using synthetic peptides
US4833071A (en) * 1987-01-09 1989-05-23 United Biomedical, Inc. Peptide composition as anitgen for detection of antibodies to HTLV-I, as a vaccine for ATL and methods therefor
AU613350B2 (en) * 1988-01-12 1991-08-01 Genelabs Technologies, Inc. Htlv-i peptide antigen and assay
JPH02209889A (ja) * 1988-02-08 1990-08-21 Univ Duke 合成親水性ペプチド
US5017687A (en) * 1988-03-10 1991-05-21 Virovahl, S.A. Peptides for the detection of HTLV-1 infection
JPH0628993A (ja) * 1992-07-10 1994-02-04 Fujitsu Ltd 電子ビーム装置

Also Published As

Publication number Publication date
AU654240B2 (en) 1994-10-27
HU906639D0 (en) 1992-02-28
KR0151860B1 (ko) 1998-10-01
KR920702688A (ko) 1992-10-06
HUT61323A (en) 1992-12-28
NZ234049A (en) 1993-02-25
AU5945390A (en) 1991-01-08
ZA904565B (en) 1991-03-27
CA2062713A1 (en) 1990-12-14
EP0814090A1 (en) 1997-12-29
WO1990015820A1 (en) 1990-12-27
FI915702A7 (sv) 1991-12-03
FI915702A0 (fi) 1991-12-03
AU4890693A (en) 1993-12-16
SE467542B (sv) 1992-08-03
SE8902148D0 (sv) 1989-06-13
EP0477301A1 (en) 1992-04-01
JPH04506077A (ja) 1992-10-22
AU638727B2 (en) 1993-07-08
JP2650217B2 (ja) 1997-09-03

Similar Documents

Publication Publication Date Title
FI904345A0 (fi) Syntetisk peptidantigen foer detektering av htlv-1 infektion.
EP0284587A3 (en) Synthetic peptide antigens for the detection of hiv-1 infection
FI882173A0 (fi) Syntetisk peptidantigen foer faststaellande av hiv-2 smitta.
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
CA2124953A1 (en) Peptides related to prion proteins
ATE198754T1 (de) Antikörper gegen saugetier-interleukin-4 und peptide verwendbar als antigenen für deren herstellung
SE8902148L (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
BR9106220A (pt) Antigenos sinteticos para a deterccao de anticorpos para o virus da hepatite c.
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
NO175639C (no) Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet
DE69026875D1 (de) Immunobestimmung von menschlichem osteocalcin, reagenz und satz dafür
DE3851492D1 (de) Ein gattungsspezifisches Listeria-Antigen, identifiziert durch monoklonale Antikörper.
DE3751834D1 (de) Selbstantigen der primären lebercirrhose
EP0439542A4 (en) Filamentous hemagglutinin of b. pertussis
ATE109004T1 (de) Toleranzinduktion gegenüber einem fremdantigen.
DE59208543D1 (de) Künstliche Standard- und Kontrollseren zur Verwendung in Verfahren zur Bestimmung von Antikörpern
ATE108663T1 (de) Treponema hyodysenteriae-antigen und seine verwendungen.
DE69128095D1 (de) Azelluläre impfstoffe
NO903760D0 (no) Syntetiske peptid antigener for detektering av htlv-1 infeksjon.
ATE90361T1 (de) Synthetische peptide und deren verwendung als allgemeine traeger fuer die herstellung von immunogenischen konjugaten, die fuer die entwicklung von synthetischen impfstoffen geeignet sind.
FI883765L (fi) Antikroppar mot biologiskt aktiva polypeptider och deras anvaendning vid diagnostiska foerfaranden.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8902148-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8902148-9

Format of ref document f/p: F